Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
about
Neuropsychological Testing and Machine Learning Distinguish Alzheimer's Disease from Other Causes for Cognitive Impairment.Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's DiseaseTau PET imaging: present and future directions.Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.Amyloid biomarkers: pushing the limits of early detection.Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's DiseaseCerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease.Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome.Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET.Added value and limitations of amyloid-PET imaging: review and analysis of selected cases of mild cognitive impairment and dementia.Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease.Astroglial activation and altered amyloid metabolism in human repetitive concussion.The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults.Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.Therapeutic potential of curcumin for multiple sclerosis.18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis.Do we still need positron emission tomography for early Alzheimer's disease diagnosis?Reply: Do we still need positron emission tomography for early Alzheimer's disease diagnosis?CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults.NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease.The Past and the Future of Alzheimer's Disease Fluid Biomarkers.Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging.A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease.Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology.Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.The EMIF-AD PreclinAD study: study design and baseline cohort overviewMRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
P2860
Q33599831-6010DE28-2EC5-4969-9CAF-F6953241FC2BQ33604453-79EC3F22-4FFB-494E-8BC4-1B7BF2315864Q33695122-87DEC190-0C43-452D-82B0-BDE15AB5F703Q34680852-2D839650-64FE-4D25-9B54-2A5901E5855BQ37198556-27BB9DDE-7FB5-4074-8BA2-4BEBC2B1629CQ37220592-2B8A45DE-9C84-46E3-AA8D-CDB69A8B2A6AQ37358410-FB99B965-3030-4DD7-8D64-355A3A7FD0DDQ37489141-AB414FE9-B9BD-4D1B-98BB-18EE0CAC0911Q37741452-0A9F1E18-5C1B-4A3E-8806-D837C448212DQ38850382-8BC029F0-58B3-4331-8486-17B1C196EDF7Q39219904-EE9AFA00-AF96-4D0E-9D37-536A27D23F7FQ39451611-3D9DC6C2-4C5F-4FFA-8E34-0249FCC87DC0Q41046609-6450A5C3-EF6F-4790-A032-9B4F1A7F05A9Q42292371-7CF8E17B-F0DC-45EE-B02C-1574EC9BD045Q42363366-FC613EC4-4683-434F-A1AF-B3539C5FCE21Q42643417-13BA5ED8-CD4B-423E-9985-C2C69C7363CBQ46045880-70959076-2DC3-449E-9CD9-D230628E18ECQ46061056-346C7B3F-55DD-45F2-8172-25ED603350B3Q46254853-2E081AD7-DD25-42AC-848C-11BD85CF34B4Q47401912-22BD077E-7406-4B21-A5A5-EB0FAECB17A5Q47549851-CA17F644-95B3-410B-9306-9CCE79C252DFQ47587631-BE9D812C-0091-42BD-9126-D45517CC9C34Q47658947-B2BCC384-2FE5-4F47-B13C-269EF141E35FQ48468789-52C0A7E8-00F5-4220-8DCA-0FDA41534BB9Q48636987-5117E239-5D04-4B6C-B5A5-60180D8EAFA4Q48636996-0B15D02E-1BBE-4A6A-93ED-CD2AF83D6801Q50533084-FDEB55DC-1D62-478B-8C9C-E79069399FB4Q51758282-05995F59-EDBD-43C5-9E7F-24D7FCD927F1Q52589491-0EB424BA-E4DE-4167-B304-39C85FC8E7DBQ52630015-3F376260-EB48-44C5-83ED-18E64A1EF51AQ52644601-E017662B-1309-4980-96EB-D9F366F7A9D8Q52675910-4EAA706C-23AE-4C4C-B883-0FA3BE1DF0CAQ54980020-A865B486-3F78-4FF4-AD0F-93BA36210D71Q55003313-05C0A162-3B5B-4EB7-B0B2-FDA4518E1ECCQ55383590-463EC514-A160-44EE-B900-DE169DC1685AQ57170740-6E692F09-7051-4537-B759-13C812874224Q59128613-35714A00-75CB-471F-8F78-ED0B7F8EE4D1
P2860
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Cerebrospinal fluid analysis d ...... n positron emission tomography
@ast
Cerebrospinal fluid analysis d ...... n positron emission tomography
@en
Cerebrospinal fluid analysis d ...... n positron emission tomography
@nl
type
label
Cerebrospinal fluid analysis d ...... n positron emission tomography
@ast
Cerebrospinal fluid analysis d ...... n positron emission tomography
@en
Cerebrospinal fluid analysis d ...... n positron emission tomography
@nl
prefLabel
Cerebrospinal fluid analysis d ...... n positron emission tomography
@ast
Cerebrospinal fluid analysis d ...... n positron emission tomography
@en
Cerebrospinal fluid analysis d ...... n positron emission tomography
@nl
P2860
P3181
P356
P1433
P1476
Cerebrospinal fluid analysis d ...... n positron emission tomography
@en
P2093
Sebastian Palmqvist
P2860
P304
P3181
P356
10.1093/BRAIN/AWW015
P407
P577
2016-04-01T00:00:00Z